Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

20

Revenue 2014

Actavis

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs.

Anish Mehta appointed CEO of new women's health business

Anish Mehta appointed CEO of new women's health business

Prior to his new role, Mehta has served at Actavis, taking the helm of its European and Middle East business, where he managed a portfolio of pharmaceutical products.

Peter Kelly named managing director of Accord Healthcare UK

Peter Kelly named managing director of Accord Healthcare UK Peter Kelly named managing director of Accord Healthcare UK. He was previously commercial director at Actavis UK. ... Choice.”. Meanwhile, former Actavis UK managing director Jonathan Wilson has been appointed vice president, West Europe at Accord

Lilly wins on appeal in Alimta vitamin regimen dispute

Lilly wins on appeal in Alimta vitamin regimen dispute Lilly wins on appeal in Alimta vitamin regimen dispute. UK Supreme Court rules in its favour over Actavis. ... The latest ruling "finds the Actavis product infringing, regardless of the diluent used in reconstitution or dilution", said Lilly in a

reactivating drug research programmes

reactivating drug research programmes Currently awaiting a possible Supreme Court hearing in the UK, the case of Warner-Lambert v Actavis will determine what conditions have to be met for a medical use claim to ... In fact, in light of Warner-Lambert v Actavis, pharmaceutical companies

MSD probed by UK for blocking Remicade biosimilars

MSD probed by UK for blocking Remicade biosimilars Last year it fined Pfizer £84m for conspiring with Flynn Pharma to raise the price of epilepsy drug phenytoin, and has since launched an investigation into the pricing of Actavis' hydrocortisone

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

Shining a light on the true cost of patient care
Sue Thomas and Paul Midgley, of Wilmington Healthcare, explore how the proposed national patient data sharing scheme would change the NHS...
city
The real-world data conundrum
How data is changing the healthcare industries...
Where is health behaviour change heading?
Cures rely on patient adherence to succeed, and health behaviour change in any non-compliant patient is essential, this post explores where health behaviour change is heading....

Infographics